Agency Forms Undergoing Paperwork Reduction Act Review, 43844-43845 [2020-15655]
Download as PDF
43844
Federal Register / Vol. 85, No. 139 / Monday, July 20, 2020 / Notices
delivery, as well as compare fatigue
between intervention groups. Potential
impacts of this project include
improvements in work behaviors for
coping with shift work and long work
hours and an objective reduction in
fatigue compared to the control groups.
This project is poised to have
considerable impact in the contribution
of an evidence base for effective
interventions that could be used by
participant will complete the sleep and
activity diary five times a day, each day
for 35 days (175 times total) which will
require approximately two minutes for
each response. There will also be three
meetings for recruitment and enrollment
(once), fitting the actigraph (weekly),
and a final meeting. The total estimated
annualized burden hours is 2,700. There
are no costs to participants other than
their time.
other taxi companies and drivers for
ride sourcing companies to promote
strategies in road safety.
The burden table lists 120 of the 180
taxi drivers in the study will complete
the online training and evaluation
(approximately three hours). All drivers
(180) will complete the Work and
Health survey, and the knowledge
survey each week of the study (five
times each per participant). Each
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondents
Form name
Taxi Drivers .......................................
Online Training & Evaluation ...........
Sleep & Activities Diary ....................
Work & Health Survey .....................
Knowledge survey ............................
Recruitment & Informed Consent ....
Initial Meeting (Fit Actigraph) ...........
10-minute meeting (turn in devices,
turn in diary, receive remuneration).
120
180
180
180
180
180
180
1
175
5
5
1
5
5
3
2/60
45/60
15/60
30/60
10/60
10/60
360
1,050
675
225
90
150
150
Total ...........................................
...........................................................
........................
........................
........................
2,700
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–15656 Filed 7–17–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–20–0576]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Possession, Use,
and Transfer of Select Agents and
Toxins to the Office of Management and
Budget (OMB) for review and approval.
CDC previously published a ‘‘Proposed
Data Collection Submitted for Public
Comment and Recommendations’’
notice on April 3, 2020 to obtain
comments from the public and affected
agencies. CDC received one comment
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
VerDate Sep<11>2014
18:30 Jul 17, 2020
Jkt 250001
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Possession, Use, and Transfer of
Select Agents and Toxins (OMB Control
No. 0920–0576, Exp. 10/31/2020)—
Revision—Center for Preparedness and
Response (CPR), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Subtitle A of the Public Health
Security and Bioterrorism Preparedness
and Response Act of 2002, (42 U.S.C.
262a), requires the United States
Department of Health and Human
Services (HHS) to regulate the
possession, use, and transfer of
biological agents or toxins that have the
potential to pose a severe threat to
public health and safety (select agents
and toxins). Subtitle B of the Public
Health Security and Bioterrorism
Preparedness and Response Act of 2002
(which may be cited as the Agricultural
Bioterrorism Protection Act of 2002), (7
U.S.C. 8401), requires the United States
Department of Agriculture (USDA) to
regulate the possession, use, and
E:\FR\FM\20JYN1.SGM
20JYN1
43845
Federal Register / Vol. 85, No. 139 / Monday, July 20, 2020 / Notices
transfer of biological agents or toxins
that have the potential to pose a severe
threat to animal or plant health, or
animal or plant products (select agents
and toxins). Accordingly, HHS and
USDA have promulgated regulations
requiring individuals or entities that
possess, use, or transfer select agents
and toxins to register with the CDC or
the Animal and Plant Health Inspection
Service (APHIS). See 42 CFR part 73, 7
CFR part 331, and 9 CFR part 121 (the
select agent regulations). The Federal
Select Agent Program (FSAP) is the
collaboration of the CDC, Division of
Select Agents and Toxins (DSAT) and
the APHIS Agriculture Select Agent
Services (AgSAS) to administer the
select agent regulations in a manner to
minimize the administrative burden on
persons subject to the select agent
regulations. The FSAP administers the
select agents regulations in close
coordination with the Federal Bureau of
Investigation’s Criminal Justice
Information Services (CJIS).
Accordingly, CDC and APHIS have
adopted an identical system to collect
information for the possession, use, and
transfer of select agents and toxins.
CDC is requesting OMB approval to
continue to collect information under
the select agent regulations through the
use of five forms: (1) Application for
Registration for Possession. Use, and
Transfer of Select Agents and Toxins
(APHIS/CDC Form 1); (2) Request to
Transfer Select Agents or Toxins
(APHIS/CDC Form 2); (3) Incident
Notification and Reporting (Theft, Loss,
or Release) (APHIS/CDC Form 3); (4)
Reporting the Identification of a Select
Agent or Toxin (APHIS/CDC Form (4);
and (5) Request for Exemption of Select
Agents and Toxins for an Investigational
Product (APHIS/CDC Form 5).
An entity may amend its registration
(42 CFR 73.7(h)(1)) if any changes occur
to the information previously submitted
to CDC. When applying for an
amendment to a certificate of
registration, an entity would complete
the relevant portion of the application
package (APHIS/CDC Form 1).
Besides the forms listed above, there
is no standard form for the following
information:
1. An individual or entity may request
an exclusion from the requirements of
the select agent regulations of an
attenuated strain of a select agent or a
select toxin modified to be less potent
or toxic. (42 CFR 73.3(e) and 73.4(e)).
2. Annual inspections that are
conducted by the entity must be
documented. (42 CFR 73.9(a)(6)).
3. An individual’s security risk
assessment may be expedited upon
written request by a Responsible Official
and a showing of good cause. (42 CFR
73.10(f)).
4. An individual or entity may request
approval to perform a ‘‘restricted
experiment’’ (42 CFR 73.13).
5. An individual or entity must
develop and implement a written
security plan, biosafety plan, and
incident response plan (42 CFR 73.11(a),
42 CFR 73.12(a), and 42 CFR 73.14(a)).
6. The Responsible Official at the
entity must ensure a record of the
training for each individual with access
to select agents and toxins and each
escorted individual is maintained (42
CFR 73.15(d)).
7. An individual or entity may appeal
a denial, revocation, or suspension of
registration. (42 CFR 73.20(a)).
8. An individual may appeal a denial,
limitation, or revocation of access
approval. (42 CFR 73.20(b)).
The total estimated annualized
burden for all data collection was
calculated using the 2018 Annual
Report of the Federal Select Agent
Program available at https://
www.selectagents.gov/
annualreport2018.html or FSAP IT
system and is estimated as 4467 hours.
Information will be collected through
FSAP IT system, fax, email and hard
copy mail from respondents. Upon OMB
approval, CDC will begin use of the
revised forms in October 2020 through
October 2023. There is no cost to the
respondents.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Section
Form name
Sections 3 & 4 ............
Sections 5 & 6 ............
Sections 5 & 6 ............
Section 7 .....................
Section 7 .....................
Section 9 .....................
Section 10 ...................
Section 11 ...................
Section 12 ...................
Section 13 ...................
Section 14 ...................
Section 15 ...................
Section 16 ...................
Section 17 ...................
Section 19 ...................
Section 20 ...................
Request for Exclusions .......................................................................
Report of Identification of a Select Agent or Toxin ............................
Request of Exemption ........................................................................
Application for Registration ................................................................
Amendment to a Certificate of Registration .......................................
Documentation of self-inspection .......................................................
Request for Expedited Review ...........................................................
Security Plan ......................................................................................
Biosafety Plan .....................................................................................
Request Regarding a Restricted Experiment .....................................
Incident Response Plan .....................................................................
Training ...............................................................................................
Request to Transfer Select Agents and Toxins .................................
Records ..............................................................................................
Notification of Theft, Loss, or Release ...............................................
Administrative Review ........................................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–15655 Filed 7–17–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
VerDate Sep<11>2014
18:30 Jul 17, 2020
Jkt 250001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
1
1,181
1
3
253
253
1
253
253
1
253
253
253
253
201
28
Number of
responses per
respondent
1
1
1
1
5
1
1
1
1
1
1
1
1
1
1
1
Average
burden per
response
(in hours)
1
1
1
5
1
1
0.5
1
1
2
1
1
1.5
0.5
1
1
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
E:\FR\FM\20JYN1.SGM
20JYN1
Agencies
[Federal Register Volume 85, Number 139 (Monday, July 20, 2020)]
[Notices]
[Pages 43844-43845]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-15655]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-20-0576]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Possession, Use, and Transfer of Select
Agents and Toxins to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
April 3, 2020 to obtain comments from the public and affected agencies.
CDC received one comment related to the previous notice. This notice
serves to allow an additional 30 days for public and affected agency
comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Possession, Use, and Transfer of Select Agents and Toxins (OMB
Control No. 0920-0576, Exp. 10/31/2020)--Revision--Center for
Preparedness and Response (CPR), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Subtitle A of the Public Health Security and Bioterrorism
Preparedness and Response Act of 2002, (42 U.S.C. 262a), requires the
United States Department of Health and Human Services (HHS) to regulate
the possession, use, and transfer of biological agents or toxins that
have the potential to pose a severe threat to public health and safety
(select agents and toxins). Subtitle B of the Public Health Security
and Bioterrorism Preparedness and Response Act of 2002 (which may be
cited as the Agricultural Bioterrorism Protection Act of 2002), (7
U.S.C. 8401), requires the United States Department of Agriculture
(USDA) to regulate the possession, use, and
[[Page 43845]]
transfer of biological agents or toxins that have the potential to pose
a severe threat to animal or plant health, or animal or plant products
(select agents and toxins). Accordingly, HHS and USDA have promulgated
regulations requiring individuals or entities that possess, use, or
transfer select agents and toxins to register with the CDC or the
Animal and Plant Health Inspection Service (APHIS). See 42 CFR part 73,
7 CFR part 331, and 9 CFR part 121 (the select agent regulations). The
Federal Select Agent Program (FSAP) is the collaboration of the CDC,
Division of Select Agents and Toxins (DSAT) and the APHIS Agriculture
Select Agent Services (AgSAS) to administer the select agent
regulations in a manner to minimize the administrative burden on
persons subject to the select agent regulations. The FSAP administers
the select agents regulations in close coordination with the Federal
Bureau of Investigation's Criminal Justice Information Services (CJIS).
Accordingly, CDC and APHIS have adopted an identical system to collect
information for the possession, use, and transfer of select agents and
toxins.
CDC is requesting OMB approval to continue to collect information
under the select agent regulations through the use of five forms: (1)
Application for Registration for Possession. Use, and Transfer of
Select Agents and Toxins (APHIS/CDC Form 1); (2) Request to Transfer
Select Agents or Toxins (APHIS/CDC Form 2); (3) Incident Notification
and Reporting (Theft, Loss, or Release) (APHIS/CDC Form 3); (4)
Reporting the Identification of a Select Agent or Toxin (APHIS/CDC Form
(4); and (5) Request for Exemption of Select Agents and Toxins for an
Investigational Product (APHIS/CDC Form 5).
An entity may amend its registration (42 CFR 73.7(h)(1)) if any
changes occur to the information previously submitted to CDC. When
applying for an amendment to a certificate of registration, an entity
would complete the relevant portion of the application package (APHIS/
CDC Form 1).
Besides the forms listed above, there is no standard form for the
following information:
1. An individual or entity may request an exclusion from the
requirements of the select agent regulations of an attenuated strain of
a select agent or a select toxin modified to be less potent or toxic.
(42 CFR 73.3(e) and 73.4(e)).
2. Annual inspections that are conducted by the entity must be
documented. (42 CFR 73.9(a)(6)).
3. An individual's security risk assessment may be expedited upon
written request by a Responsible Official and a showing of good cause.
(42 CFR 73.10(f)).
4. An individual or entity may request approval to perform a
``restricted experiment'' (42 CFR 73.13).
5. An individual or entity must develop and implement a written
security plan, biosafety plan, and incident response plan (42 CFR
73.11(a), 42 CFR 73.12(a), and 42 CFR 73.14(a)).
6. The Responsible Official at the entity must ensure a record of
the training for each individual with access to select agents and
toxins and each escorted individual is maintained (42 CFR 73.15(d)).
7. An individual or entity may appeal a denial, revocation, or
suspension of registration. (42 CFR 73.20(a)).
8. An individual may appeal a denial, limitation, or revocation of
access approval. (42 CFR 73.20(b)).
The total estimated annualized burden for all data collection was
calculated using the 2018 Annual Report of the Federal Select Agent
Program available at https://www.selectagents.gov/annualreport2018.html
or FSAP IT system and is estimated as 4467 hours. Information will be
collected through FSAP IT system, fax, email and hard copy mail from
respondents. Upon OMB approval, CDC will begin use of the revised forms
in October 2020 through October 2023. There is no cost to the
respondents.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Section Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Sections 3 & 4........................ Request for Exclusions.. 1 1 1
Sections 5 & 6........................ Report of Identification 1,181 1 1
of a Select Agent or
Toxin.
Sections 5 & 6........................ Request of Exemption.... 1 1 1
Section 7............................. Application for 3 1 5
Registration.
Section 7............................. Amendment to a 253 5 1
Certificate of
Registration.
Section 9............................. Documentation of self- 253 1 1
inspection.
Section 10............................ Request for Expedited 1 1 0.5
Review.
Section 11............................ Security Plan........... 253 1 1
Section 12............................ Biosafety Plan.......... 253 1 1
Section 13............................ Request Regarding a 1 1 2
Restricted Experiment.
Section 14............................ Incident Response Plan.. 253 1 1
Section 15............................ Training................ 253 1 1
Section 16............................ Request to Transfer 253 1 1.5
Select Agents and
Toxins.
Section 17............................ Records................. 253 1 0.5
Section 19............................ Notification of Theft, 201 1 1
Loss, or Release.
Section 20............................ Administrative Review... 28 1 1
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-15655 Filed 7-17-20; 8:45 am]
BILLING CODE 4163-18-P